1-17 of 17
Cong Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Clinical Trials & Observations
Ola Landgren, Thomas J. Prior, Tara Masterson, Christoph Heuck, Orlando F. Bueno, Ajeeta B. Dash, Hermann Einsele, Hartmut Goldschmidt, Stefan Knop, Cong Li, Ulf-Henrik Mellqvist, Ian McFadden, Corina Oprea, Jeremy A. Ross, Mihaela Talpes, Jay R. Hydren, Jennifer M. Ahlstrom, Dickran Kazandjian, Niels Weinhold, Rick Zhang, Maryalice Stetler-Stevenson, Gerald Marti, Sean M. Devlin
Journal: Blood
Blood (2024) 144 (4): 359–367.
https://doi.org/10.1182/blood.2024024371
Published: 2024
Includes: Supplemental data
Journal Articles

PD-1 Blockade Combined with R-CHOP in Patients with Newly Diagnosed EBV-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Analysis

Xi Chen, Yingying Chen, Tao Lei, Haifeng Yu, Cong Li, Yongwei Hong, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4506.
https://doi.org/10.1182/blood-2023-182685
Published: 2023
Journal Articles

Gp350-Targeted CAR-T Therapy in EBV-Positive NK/T-Cell Lymphoma: Pre-Clinical Development of gp350CAR-T

Zhimai Gao, Fan Wu, Cong Li, Huiping Wang, Xue Liang, Zhimin Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 4810.
https://doi.org/10.1182/blood-2023-184785
Published: 2023
Journal Articles

Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive B-Cell Lymphoma

Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6227.
https://doi.org/10.1182/blood-2023-184694
Published: 2023
Journal Articles

Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study

Weijun Fu, Juan Du, Lu Zhong, Lijuan Chen, Jian Li, Donghua Zhang, Jianqing Mi, Yan Liu, Sheng Wu, Richard Labotka, Cong Li, Wenhan Jiang, Wenming Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6735.
https://doi.org/10.1182/blood-2023-181444
Published: 2023
Journal Articles

A Prospective, Exploratory, Phase II Study of the Xpo-1 Inhibitor Selinexor in Combination with RCHOP in Double/Triple-Hit Large B-Cell Lymphoma

Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6242.
https://doi.org/10.1182/blood-2023-184634
Published: 2023
Journal Articles

Real-World Analysis of Obinutuzumab-Based Immunochemotherapy in Follicular Lymphoma in Chinese Population

Xi Chen, Jieyu Xu, Haifeng Yu, Tao Lei, Cong Li, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6311.
https://doi.org/10.1182/blood-2023-189282
Published: 2023
Journal Articles

Updated Results of a Prospective Study: Rituximab and Lenalidomide Plus Chidamide (RLC) for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma

Cong Li, Huixian HU, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han, Haiyan Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6221.
https://doi.org/10.1182/blood-2023-184830
Published: 2023
Journal Articles

TGF-β Inhibitor SD-208 Enhances the Anti-Tumor Efficacy of CD19 CAR-T Cells through a Reduction of CAR-Treg in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Cong Li, Huiping Wang, Xue Liang, Ying Pan, Jiyu Wang, Qiang Hong, Qianshan Tao, Yanghua Tian, Zhimin Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 6831.
https://doi.org/10.1182/blood-2023-184401
Published: 2023
Journal Articles

MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

Clinical Trials & Observations
Bruno Paiva, Irene Manrique, Meletios A. Dimopoulos, Francesca Gay, Chang-Ki Min, Sonja Zweegman, Ivan Špička, Raphael Teipel, María-Victoria Mateos, Nicola Giuliani, Michele Cavo, Christine Rojas Hopkins, Weijun Fu, Kaveri Suryanarayan, Alexander Vorog, Cong Li, Bingxia Wang, Jose Estevam, Richard Labotka, Ajeeta B. Dash
Journal: Blood
Blood (2023) 141 (6): 579–591.
https://doi.org/10.1182/blood.2022016782
Published: 2023
Includes: Supplemental data
Journal Articles

Co-Occurrence of High-Risk Lesions Is a Consistent Predictor of Ultra-High Risk Multiple Myeloma in Newly Diagnosed and Relapsed/Refractory Patients - Meta-Analysis of 5,808 Trial Patients

Martin F. Kaiser, Pieter Sonneveld, David Cairns, Marc S Raab, Alessandra Larocca, Sarah R Brown, Marc-A. Baertsch, Cong Li, Pellegrino Musto, Kwee Yong, Elias K Mai, Andrea Capra, Gordon Cook, Hartmut Goldschmidt, Mario Boccadoro, Graham Jackson, Niels Weinhold, Francesca Gay
Journal: Blood
Blood (2022) 140 (Supplement 1): 1556–1558.
https://doi.org/10.1182/blood-2022-160130
Published: 2022
Journal Articles

Rituximab and Lenalidomide Plus Chidamide Can be an Effective Chemotherapy Regimen for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma

Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3689–3690.
https://doi.org/10.1182/blood-2022-166370
Published: 2022
Journal Articles

"Gentle Initiation” Rituximab, Lenalidomide and Zanubrutinib Chemo-Free Regimen Followed By Immunochemotherapy for Elderly/Frail Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Investigator Initiated, Single Arm, Phase 2 Trial

Xi Chen, Tao Lei, Haifeng Yu, Cong Li, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9452–9453.
https://doi.org/10.1182/blood-2022-164486
Published: 2022
Journal Articles

The Combination of Bortezomib with Cyclophosphamide, Epirubicin, Etoposide and Prednisone (BCHEP) Regimen As First-Line Treatment for Untreated Patients with Peripheral T Cell Lymphoma: A Prospective, Single Arm, Phase II Study

Haiyan Yang, Cong Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 2482.
https://doi.org/10.1182/blood-2021-149541
Published: 2021
Journal Articles

Prognostic Importance of Measurable Residual Disease (MRD) Kinetics and Progression-Free Survival (PFS) Benefit in MRD+ Patients (Pts) with Ixazomib Vs Placebo As Post-Induction Maintenance Therapy: Results from the Multicenter, Double-Blind, Phase 3 TOURMALINE-MM4 Trial in Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM) Pts

Bruno Paiva, PhD, Irene Manrique, PhD, Nicola Giuliani, Michele Cavo, Christine Rojas, MD, Weijun Fu, MD PhD, María-Victoria Mateos, MD PhD, Meletios A Dimopoulos, Alexander Vorog, MD, Cong Li, PhD, Bingxia Wang, PhD, Richard J Labotka, MD, Ajeeta B Dash, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-136105
Published: 2020
Journal Articles

Potential Metabolites with Diagnostic Value in Plasma for Angioimmunoblastic T-Cell Lymphoma By LC-MS Based Untargeted Metabonomics Study

Haiyan Yang, Tao Lei, Cong Li, Haifeng Yu, Zhongjian Chen
Journal: Blood
Blood (2019) 134 (Supplement_1): 5234.
https://doi.org/10.1182/blood-2019-129897
Published: 2019
Journal Articles

PDK1 Controls the Differentiation of Hematopoietic Stem Cells Via Modulating ROS Levels

Tianyuan Hu, PhD, Cong Li, Le Wang, Yingchi Zhang, Luyun Peng, Weili Wang, Xiaomin Wang, Yajing Chu, Yingdai Gao, Bing Liu, Zhenyu Ju, Tao Cheng, MD, Weiping Yuan, PhDMD
Journal: Blood
Blood (2015) 126 (23): 896.
https://doi.org/10.1182/blood.V126.23.896.896
Published: 2015